Demography | |
---|---|

Age (years), mean (SD) | 53 (13) |

Sex, female, n (%) | 84 (82) |

Disease duration years, median (range) | 8 (1–49) |

Erosive disease, n (%) | 84 (82) |

IgM-RF positive, n (%) | 75 (74) |

Disease activity | |
---|---|

DAS-28, mean (SD) | 5.4 (1.2) |

ESR (mm/h), mean (SD) | 32 (23) |

CRP (mg/l), median (range) | 14 (1–174) |

Drugs | |
---|---|

Methotrexate, n (%) | 98 (96) |

Prednisone, n (%) | 46 (45) |

Anti-osteoporotic drugs, n (%) | 26 (26) |

BMD | |
---|---|

BMD, bone mineral; CRP, C reactive protein, DAS-28, Disease Activity Score of 28 joints; ESR, erythrocyte sedimentation rate; IgM-RF, immunoglobulin G-rheumatoid factor. | |

Vertebral spine (g/cm^{2}), mean (SD), n = 102 | 0.993 (0.19) |

t Score, mean (SD) | −0.82 (1.6) |

z Score, mean (SD) | −0.09 (1.5) |

Total hip (g/cm^{2}), mean (SD), n = 89 | 0.830 (0.14) |

t Score, mean (SD) | −1.02 (1.2) |

z Score, mean (SD) | −0.51 (1.2) |

Hand, mean (SD), n = 53 | 0.497 (0.98) |